Skip to content

Doctor-led laser treatment for benign vascular lesions — cherry angiomas, Campbell de Morgan spots, small haemangiomas and facial telangiectasia. Long-pulsed 1064 nm Nd:YAG is delivered at individualised settings after a medical consultation to confirm diagnosis and assess pigmentation risk. Most lesions clear in 1–3 sessions with minimal downtime. Suspicious lesions are diagnosed, not lasered.

Vascular laser

Vascular Spot Laser Treatment

Doctor-led laser treatment for benign vascular lesions — cherry angiomas, Campbell de Morgan spots, small haemangiomas and facial telangiectasia. Long-pulsed 1064 nm Nd:YAG is delivered at individualised settings after a medical consultation to confirm diagnosis and assess pigmentation risk. Most lesions clear in 1–3 sessions with minimal downtime. Suspicious lesions are diagnosed, not lasered.

Portrait of Dr Christopher Irwin

By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA

Last reviewed 2026-06-06 · Editorial policy

Quick definition

Vascular spot laser at The Skin Doctor is doctor-led laser treatment for benign vascular lesions — cherry angiomas, Campbell de Morgan spots, small haemangiomas and facial telangiectasia (broken capillaries). Treatment uses a long-pulsed 1064 nm Nd:YAG laser, with settings individualised for lesion type, depth and skin tone. The guiding principle is accurate diagnosis first, careful treatment second — suspicious or atypical lesions are biopsied or referred rather than lasered. Most lesions clear in 1–3 sessions with minimal downtime.

Benign vascular spots such as cherry angiomas, Campbell de Morgan spots and small haemangiomas are common and usually harmless, but they can be cosmetically bothersome or prone to catching, bleeding or irritation. Visible facial broken capillaries (telangiectasia) and rosacea-related vessels are equally treatable with the same technology.

At The Skin Doctor, we provide doctor-led laser treatment for selected vascular lesions, with a simple guiding principle: accurate diagnosis first, careful treatment second. Because vascular lesions vary in depth, behaviour and appearance, a medical assessment is essential before any laser is used.

If your concern is background redness or flushing rather than individual spots, see the merged Rosacea hub — vascular laser is the most durable treatment for the visible-vessel component of rosacea.

What are vascular spots?

Vascular spots are benign collections of superficial blood vessels within the skin. The most common types we treat:

  • Cherry angiomas — small, bright red or purple vascular bumps that become more common with age.
  • Campbell de Morgan spots — another name for larger or more dome-shaped cherry angiomas.
  • Small haemangiomas — benign vascular growths often present from childhood, or occasionally appearing later in life.
  • Telangiectasia (broken capillaries) — visible clusters of small, dilated blood vessels, most commonly on the face, around the nose and cheeks.

These lesions are generally harmless, but many people seek treatment for cosmetic reasons or because the lesion bleeds, catches, grows or becomes irritated.

Why a doctor-led consultation matters

Before treating any vascular lesion with laser, your doctor will:

  • take a medical history, including medications, anticoagulants and relevant skin conditions
  • examine the lesion to confirm it is benign
  • assess your skin type and risk of pigmentation or scarring
  • determine whether laser is appropriate — or whether monitoring, biopsy or referral is the right pathway
  • discuss the expected number of treatments
  • explain downtime, aftercare and cost

If a lesion appears suspicious or atypical, laser treatment will not be performed and appropriate medical follow-up will be advised instead. This is the most important step in the pathway — vascular and pigmented skin cancers can occasionally mimic benign vascular spots, and lasering them risks both diagnostic delay and worse cosmetic outcomes.

How the laser works

The long-pulsed 1064 nm Nd:YAG laser delivers controlled energy that is selectively absorbed by haemoglobin (the pigment in blood). This gently heats and collapses the targeted vessel while leaving surrounding skin largely unaffected.

The 1064 nm Nd:YAG wavelength is widely used in medical practice for vascular work because:

  • it penetrates deeper than shorter vascular wavelengths — useful for deeper or more resistant vascular lesions
  • it can safely treat a broader range of vessel types and sizes
  • it has the best safety profile of any vascular wavelength in darker Fitzpatrick skin types, when delivered with conservative settings

Laser parameters — fluence, pulse duration, spot size — are carefully selected based on lesion type and depth, vessel size and colour, your skin tone, and treatment location. This individualised approach maximises effectiveness while prioritising safety.

What to expect during treatment

On the day. The skin is cleansed and protective eyewear is applied. Precise pulses of laser light are delivered to the lesion. You may feel a brief snapping or warm sensation. Cooling may be used depending on the device. Many small vascular spots require only a few pulses.

After treatment. It is common to experience temporary redness, mild swelling, darkening or greying of the treated spot, and light crusting as the lesion resolves. These effects usually settle over several days. Most patients return to normal activities immediately unless advised otherwise.

How many treatments are needed?

This depends on lesion type and depth:

  • small cherry angiomas — often 1–2 sessions
  • flat vascular spots — 1–3 sessions
  • deeper or thicker haemangiomas — may require multiple sessions
  • broken capillaries — often treated in a staged series

Your specific plan is confirmed at the consultation.

Medicare and vascular laser

In certain clinical circumstances, vascular laser treatment of head/neck vascular abnormalities may be eligible for a Medicare rebate under item 14100.

Key points:

  • eligibility depends on your individual clinical presentation and whether MBS criteria are met
  • not all vascular laser treatments are rebatable
  • patients who have reached the Extended Medicare Safety Net threshold may find Medicare contributes a higher proportion of the cost of eligible services for the remainder of the calendar year
  • no guarantees can be made prior to assessment

The Rosacea hub contains a more detailed Medicare 14100 explainer for the persistent-redness pathway — it applies in the same way for individual vascular spots on the head and neck.

Risks and considerations

All medical laser treatments carry risks. Possible risks include:

  • temporary darkening of the lesion
  • redness or swelling
  • mild blistering or crusting
  • post-inflammatory hyperpigmentation (more common in darker skin types and after sun exposure)
  • recurrence of vascular lesions over time, or formation of new vascular spots elsewhere
  • rarely, scarring

Strict sun protection is recommended after treatment to reduce pigmentation risk.

Is laser suitable for all skin types?

Laser treatment for vascular lesions is generally safest in lighter skin types, but long-pulsed 1064 nm Nd:YAG is the safest vascular wavelength for medium-to-darker skin tones when used cautiously — with longer pulse durations, lower fluences and a test-spot approach. Patients in this group are often reviewed via our Skin of Colour Clinic pathway.

Book a vascular spot assessment

If you have a vascular spot, cherry angioma or facial broken capillary you would like assessed, the booking panel in the sidebar takes you to the consultation appointment.

You may also find these helpful:


What to expect

  1. Doctor-led consultation and diagnosis

    Medical history, lesion examination to confirm benign nature, skin-type assessment for pigment risk, and discussion of expected sessions, downtime, aftercare and cost. Suspicious or atypical lesions are not treated — appropriate medical follow-up (biopsy or referral) is advised instead.

  2. Preparation and eye protection

    The skin is cleansed and protective eyewear fitted. Photosensitising medications, anticoagulants, recent isotretinoin, pregnancy / breastfeeding status and any history of pigmentation problems are reconfirmed before treatment proceeds.

  3. Long-pulsed 1064 nm Nd:YAG laser delivery

    Precise pulses are delivered to the lesion. Energy is selectively absorbed by haemoglobin, gently heating and collapsing the targeted vessel while preserving surrounding skin. Settings — fluence, pulse duration, spot size — are individualised for lesion type, depth, colour, body location and skin tone.

  4. Cooling and immediate aftercare

    Cooling may be used during or after treatment depending on the device, with simple written post-care instructions covering sun protection, gentle skincare, and what darkening or crusting to expect.

  5. Review and staged plan

    A review is scheduled where appropriate to assess response and plan further sessions. Most facial vascular spots respond within 1–3 sessions; deeper or thicker lesions may need a longer staged course.

Results timeline

  • Immediately after treatment Temporary redness, mild swelling and darkening or greying of the treated spot are common. Light crusting may follow as the lesion resolves. Most patients return to normal activities immediately.
  • Days to 2 weeks Treated lesions fade or scab and clear. Mild bruising occasionally occurs. Strict sun protection is important through this window to minimise post-inflammatory pigmentation, particularly in medium-to-darker skin types.
  • 4–8 weeks Review point for staged plans. Small cherry angiomas often clear in 1–2 sessions; flat vascular spots typically clear in 1–3 sessions; broken capillaries are treated in a staged series.
  • 3–6 months Final clearance assessed across the treatment course. Deeper or thicker haemangiomas may require additional sessions. New vascular spots can develop over time due to genetics, ageing or sun exposure and are not a sign that the original treatment failed.

Ideal candidate

  • Adults with benign vascular lesions confirmed by a doctor — cherry angiomas, Campbell de Morgan spots, small haemangiomas or facial telangiectasia.
  • Patients with visible facial broken capillaries seeking targeted laser clearance.
  • Patients with rosacea-related visible vessels or background redness (typically managed via the merged Rosacea hub — vascular laser is the most durable treatment for the vessel component).
  • Patients with raised cherry angiomas that catch on clothing, bleed when knocked, or irritate during shaving.
  • Patients who have tried IPL or other vascular devices elsewhere and want a long-pulsed Nd:YAG-based approach for resistant or deeper vessels.
  • Lighter skin types preferred; medium-to-darker Fitzpatrick skin can be treated cautiously with conservative settings, longer pulse durations and pigmentation-risk planning.
  • Patients with new, growing or recently changed vascular-looking lesions who want a doctor-led diagnosis before any laser is used.
  • Patients comfortable with a staged plan — 1–3 sessions is typical for facial vascular work, more for deeper or thicker lesions.

Frequently asked questions

  • What's the difference between vascular spot laser and the laser facial / leg veins treatment?
    This page covers discrete vascular lesions — cherry angiomas, Campbell de Morgan spots, small haemangiomas, and individual facial broken capillaries. The laser facial & leg veins page covers larger superficial vessels — facial spider veins and selected leg telangiectasia or reticular veins up to about 3 mm. Both use long-pulsed 1064 nm Nd:YAG, but the indication, planning and number of sessions differ. The right page is confirmed at consultation.
  • Are vascular spots dangerous?
    Most cherry angiomas, Campbell de Morgan spots and small haemangiomas are benign. A doctor-led consultation confirms diagnosis before treatment so that suspicious or atypical lesions are not mistaken for a vascular spot — new, growing or recently changed lesions are diagnosed properly before any laser is used, and biopsied or referred where appropriate rather than ablated.
  • Will the spot come back?
    Treated lesions often clear or fade significantly and the treated vessel itself usually does not return. New vascular spots can appear over time due to genetics, ageing or sun exposure — this is the underlying tendency to form them, not a failure of the original treatment. Daily SPF and trigger management slow the rate at which new spots develop.
  • Is treatment painful?
    Most patients describe a brief snapping or warm sensation that is well tolerated. Cooling may be used during or after treatment for comfort, depending on the device. No general anaesthetic is needed; for sensitive patients or larger areas, topical numbing can be discussed at consultation.
  • Is there downtime?
    Downtime is usually minimal. Some lesions darken or grey before flaking off over several days. Mild swelling or redness is common immediately after treatment, typically settling within hours to a few days. Most patients return to work and normal activities the same day. Strict sun protection is important through the healing window.
  • Is vascular laser ever Medicare-rebatable?
    In certain clinical circumstances, vascular laser treatment of head/neck vascular abnormalities may be eligible for a Medicare rebate under item 14100. Eligibility depends on your individual clinical presentation and whether MBS criteria are met. Not all vascular laser treatments are rebatable, and no guarantees can be made prior to assessment. Patients who have reached their Extended Medicare Safety Net threshold may find Medicare contributes a higher proportion of the cost of eligible services for the remainder of the calendar year. This is discussed in detail at consultation. The Rosacea hub contains a more detailed Medicare 14100 explainer for the rosacea / persistent-redness pathway.
  • Is vascular laser safe for darker skin types?
    Long-pulsed 1064 nm Nd:YAG is the safest laser wavelength for darker skin because it bypasses much of the melanin in the epidermis and targets the deeper haemoglobin in vessels. Treatment is still individualised and conservative for melanin-rich skin (Fitzpatrick IV–VI) — longer pulse durations, lower fluences, and a cautious test-spot approach. Patients in this group are often reviewed through our Skin of Colour Clinic pathway.
  • When is vascular laser not the right treatment?
    Vascular laser is not the right pathway for: suspicious or recently changed pigmented lesions (these need diagnosis first); bulging varicose veins driven by deeper venous disease (referral needed); active skin infection over the treatment area; recent significant sun exposure or sunburn; pregnancy (deferred until after delivery for elective vascular work); or patients on certain photosensitising medications without dose review. These are all assessed at consultation.

References

  1. Pulsed dye laser versus intense pulsed light for facial erythema of rosacea — a systematic review and meta-analysis. J Dermatolog Treat. 2022.DOI: 10.1080/09546634.2021.1959507
  2. Light-based therapies in the management of rosacea — a systematic review with meta-analysis. Int J Dermatol. 2022.DOI: 10.1111/ijd.15680

Related


Medically reviewed by Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA · Last reviewed 2026-06-06 · Editorial policy